Jay C Jha1, Aozhi Dai1, Chet E Holterman2, Mark E Cooper1, Rhian M Touyz3, Chris R Kennedy2, Karin A M Jandeleit-Dahm4,5. 1. Department of Diabetes, Central Clinical School, Monash University, 99 Commercial Road, Level 5, Melbourne, VIC, 3004, Australia. 2. Department of Medicine, Kidney Research Centre, Ottawa Hospital Research Institute, Ottawa, ON, Canada. 3. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. 4. Department of Diabetes, Central Clinical School, Monash University, 99 Commercial Road, Level 5, Melbourne, VIC, 3004, Australia. karin.jandeleit-dahm@monash.edu. 5. German Diabetes Centre, Institute for Clinical Diabetology, Leibniz Centre for Diabetes Research, Heinrich-Heine University, Duesseldorf, Germany. karin.jandeleit-dahm@monash.edu.
Abstract
AIMS/HYPOTHESIS: Excessive production of reactive oxygen species (ROS) plays a detrimental role in the progression of diabetic kidney disease (DKD). Renal oxidative stress activates proinflammatory cytokines, chemokines and profibrotic factors in DKD. Increased expression of the prooxidant enzyme NADPH oxidase (NOX) 5 in kidneys of diabetic individuals has been hypothesised to correlate with renal injury and progression of DKD. Since the gene encoding NOX5 is not expressed in the mouse genome, we examined the effect of inducible human NOX5 expression in renal cells, selectively in either endothelial cells or vascular smooth muscle cells (VSMCs)/mesangial cells in a model of insulin-deficient diabetes, the Akita mouse. METHODS: Renal structural injury, including glomerulosclerosis, mesangial expansion and extracellular matrix protein accumulation, as well as renal inflammation, ROS formation and albuminuria, were examined in the NOX5 transgenic Akita mouse model of DKD. RESULTS: Expression of NOX5 in either endothelial cells or VSMCs/mesangial cells in diabetic Akita mice was associated with increased renal inflammation (monocyte chemoattractant protein-1, NF-κB and toll-like receptor-4) and glomerulosclerosis, as well as upregulation of protein kinase C-α and increased expression of extracellular matrix genes (encoding collagen III, fibronectin and α-smooth muscle actin) and proteins (collagen IV), most likely mediated via enhanced renal ROS production. The effect of VSMC/mesangial cell-specific NOX5 expression resulted in more pronounced renal fibrosis in comparison with endothelial cell-specific NOX5 expression in diabetic mice. In addition, albuminuria was significantly increased in diabetic VEcad+NOX5+ mice (1192 ± 194 μg/24 h) when compared with diabetic VEcad+NOX5- mice (770 ± 98 μg/24 h). Furthermore, the regulatory components of NOX5 activation, including heat shock protein 90 and transient receptor potential cation channel subfamily C member 6, were upregulated only in the presence of both NOX5 and diabetes. CONCLUSIONS/ INTERPRETATION: The findings from this study highlight the importance of NOX5 in promoting diabetes-related renal injury and provide the rationale for the development of a selective NOX5 inhibitor for the prevention and/or treatment of DKD.
AIMS/HYPOTHESIS: Excessive production of reactive oxygen species (ROS) plays a detrimental role in the progression of diabetic kidney disease (DKD). Renal oxidative stress activates proinflammatory cytokines, chemokines and profibrotic factors in DKD. Increased expression of the prooxidant enzyme NADPH oxidase (NOX) 5 in kidneys of diabetic individuals has been hypothesised to correlate with renal injury and progression of DKD. Since the gene encoding NOX5 is not expressed in the mouse genome, we examined the effect of inducible humanNOX5 expression in renal cells, selectively in either endothelial cells or vascular smooth muscle cells (VSMCs)/mesangial cells in a model of insulin-deficient diabetes, the Akita mouse. METHODS:Renal structural injury, including glomerulosclerosis, mesangial expansion and extracellular matrix protein accumulation, as well as renal inflammation, ROS formation and albuminuria, were examined in the NOX5 transgenic Akita mouse model of DKD. RESULTS: Expression of NOX5 in either endothelial cells or VSMCs/mesangial cells in diabetic Akitamice was associated with increased renal inflammation (monocyte chemoattractant protein-1, NF-κB and toll-like receptor-4) and glomerulosclerosis, as well as upregulation of protein kinase C-α and increased expression of extracellular matrix genes (encoding collagen III, fibronectin and α-smooth muscle actin) and proteins (collagen IV), most likely mediated via enhanced renal ROS production. The effect of VSMC/mesangial cell-specific NOX5 expression resulted in more pronounced renal fibrosis in comparison with endothelial cell-specific NOX5 expression in diabeticmice. In addition, albuminuria was significantly increased in diabeticVEcad+NOX5+ mice (1192 ± 194 μg/24 h) when compared with diabeticVEcad+NOX5- mice (770 ± 98 μg/24 h). Furthermore, the regulatory components of NOX5 activation, including heat shock protein 90 and transient receptor potential cation channel subfamily C member 6, were upregulated only in the presence of both NOX5 and diabetes. CONCLUSIONS/ INTERPRETATION: The findings from this study highlight the importance of NOX5 in promoting diabetes-related renal injury and provide the rationale for the development of a selective NOX5 inhibitor for the prevention and/or treatment of DKD.
Authors: Mark E Molitch; Ralph A DeFronzo; Marion J Franz; William F Keane; Carl Erik Mogensen; Hans-Henrik Parving; Michael W Steffes Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112
Authors: A M D Watson; J Li; C Schumacher; M de Gasparo; B Feng; M C Thomas; T J Allen; M E Cooper; K A M Jandeleit-Dahm Journal: Diabetologia Date: 2009-10-28 Impact factor: 10.122
Authors: Jay C Jha; Stephen P Gray; David Barit; Jun Okabe; Assam El-Osta; Tamehachi Namikoshi; Vicki Thallas-Bonke; Kirstin Wingler; Cedric Szyndralewiez; Freddy Heitz; Rhian M Touyz; Mark E Cooper; Harald H H W Schmidt; Karin A Jandeleit-Dahm Journal: J Am Soc Nephrol Date: 2014-02-07 Impact factor: 10.121
Authors: Jay C Jha; Vicki Thallas-Bonke; Claudine Banal; Stephen P Gray; Bryna S M Chow; Georg Ramm; Susan E Quaggin; Mark E Cooper; Harald H H W Schmidt; Karin A Jandeleit-Dahm Journal: Diabetologia Date: 2015-10-28 Impact factor: 10.122
Authors: Vicki Thallas-Bonke; Jay C Jha; Stephen P Gray; David Barit; Hermann Haller; Harald H H W Schmidt; Melinda T Coughlan; Mark E Cooper; Josephine M Forbes; Karin A M Jandeleit-Dahm Journal: Physiol Rep Date: 2014-11-03
Authors: Kathy K Griendling; Livia L Camargo; Francisco J Rios; Rhéure Alves-Lopes; Augusto C Montezano; Rhian M Touyz Journal: Circ Res Date: 2021-04-01 Impact factor: 17.367
Authors: Mahmoud H Elbatreek; Sepideh Sadegh; Elisa Anastasi; Emre Guney; Cristian Nogales; Tim Kacprowski; Ahmed A Hassan; Andreas Teubner; Po-Hsun Huang; Chien-Yi Hsu; Paul M H Schiffers; Ger M Janssen; Pamela W M Kleikers; Anil Wipat; Jan Baumbach; Jo G R De Mey; Harald H H W Schmidt Journal: PLoS Biol Date: 2020-11-10 Impact factor: 8.029